세계의 조제 약국 시장 : 제품 유형별, 용도별, 치료 영역별, 배합 유형별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Compounding Pharmacies Market, By Product Type, By Application, By Therapeutic areas, By Compounding Type, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

US $ 3,250 ￦ 4,520,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 4,650 ￦ 6,467,000

PDF (5 User License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 5,650 ￦ 7,858,000

PDF & Excel (Enterprise User License)

PDF & Excel 보고서를 동일 기업 내 모든 사용자가 사용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

세계 조제 약국 시장 규모는 2022년 126억 870만 달러로 2023년부터 2030년까지 연평균 6.3%의 성장률을 보일 것으로 예상됩니다.

조제 약국 시장 - 시장 역학

• 만성질환 유병률 증가, 노인 인구 증가, 평균수명 증가가 시장 수요를 촉진할 것으로 예상됨.
• 만성 질환은 종종 장기적인 치료가 필요한 경우가 많습니다. 약국은 환자의 고유한 요구사항에 맞게 의약품을 조정하여 용량과 제형을 최대화하거나 특정 요구사항이 있는 환자를 위해 효능과 내약성을 개선할 수 있습니다. 미국 전체 인구의 40% 이상에 해당하는 약 143만 명의 미국인에게 영향을 미치고 있으며, 2020년까지 이 숫자는 약 157만 명으로 증가할 것으로 예상되며, 8,100만 명은 여러 질환을 앓고 있는 것으로 추정됩니다. 노인 인구가 증가함에 따라 이 연령층을 위한 의료 서비스 및 시설 측면에서도 노인의학 전문 의료에 대한 요구가 증가하고 있습니다. 평균 수명이 길어짐에 따라 삶의 질을 보장하기 위한 예방의학이 강조되고 있습니다. 이는 웰니스, 영양, 검진 산업을 강화할 수 있습니다. 개발도상국에는 큰 발전 기회가 있습니다. 이러한 지역에서는 의식과 소득 수준이 향상됨에 따라 맞춤형 치료에 대한 수요가 증가할 수 있습니다. 그러나 조제 약국이 때때로 경험하는 엄격한 규제 감독에 문제가 있습니다. 이는 시장 성장에 걸림돌이 되고 있습니다.

조제 약국 시장 - 세분화 분석

• 세계 조제 약국 시장은 제품 유형, 치료 분야, 응용 분야, 제형 유형 및 지역에 따라 세분화됩니다.
• 시장은 제품 유형에 따라 경구제, 국소제, 직장제, 비경구제, 비강제, 안과제, 구강청결제 등 7가지 범주로 나뉩니다. 시장을 독점하고 있는 것은 경구제입니다. 복용의 용이성, 환자의 순응도, 제형의 다양성(정제, 캡슐, 액상, 현탁액 등)으로 인해 경구 투여는 여전히 가장 인기 있는 약물전달 수단 중 하나입니다.
• 시장은 치료 영역별로 통증 관리, 호르몬 대체 요법(HRT), 피부과, 전문의약품 등 4개 카테고리로 분류됩니다. 호르몬 대체요법(HRT) 분야가 시장을 주도하고 있습니다. 조제 약국은 호르몬 대체요법(HRT) 분야에서 중요한 역할을 하고 있는데, HRT는 갱년기, 남성 갱년기('남성 갱년기'라고도 함), 내분비 질환 등에 따른 체내 호르몬 이상을 치료하기 위한 호르몬제입니다.
• 시장은 용도에 따라 소아, 성인, 노인, 동물 등 4가지로 나뉩니다. 소아, 성인, 노인, 동물 등 4가지로 분류됩니다. 노년층이 시장을 독점하고 있으며, 예측 기간 동안에도 그 우위를 유지할 것으로 보입니다. 조제 약국은 노인 건강 관리 분야에서 중요한 역할을 하고 있습니다. 노년층은 다약제 복용, 노화에 따른 생리적 변화, 특정 약물 감수성, 약물 관리 문제 등의 요인으로 인해 독특한 처방전 요구가 있는 경우가 많습니다.

조제 약국 시장 - 지리적 인사이트

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카로 나뉩니다. 이 지역은 비지니스를 가져오는 국가에 따라 더 세분화됩니다. 북미는 복합제에 대한 지역적 인지도와 의료 시설의 증가로 인해 시장 성장을 주도할 것으로 예상됩니다. 수년 동안 미국과 캐나다는 의료 인프라에 많은 투자를 해왔습니다. The U.S. Health Care from a Global Perspective는 2021년 미국이 국내총생산(GDP)의 17.8%를 의료비로 지출할 것으로 예상하고 있습니다. 이는 OECD 회원국 평균의 약 2배에 해당합니다. 유럽은 높은 인지도, 명확한 규제, 경제력, 기술 혁신으로 인해 조제 약국에서 두 번째로 큰 시장으로 부상하고 있습니다.

조제 약국 시장 - 경쟁 상황

많은 분야와 마찬가지로, 조제 약국 산업의 경쟁 환경은 많은 주요 기업, 지역 기업 및 지역 독립 약국의 존재에 의해 정의됩니다. 이들 조직은 종종 품질, 서비스 범위, 규제 준수, 기술 향상 및 지리적 범위에 따라 경쟁합니다. 시장 점유율은 위치 및 각 기업이 차지하는 조제 내 정확한 틈새 시장에 따라 달라집니다. 수익 측면에서는 여러 지점을 보유한 대기업이 우위를 차지할 수 있지만, 지역 독립 약국이 지역 시장에서 큰 점유율을 차지할 수 있습니다.

일부 약국들은 조제 정확도, 품질 관리, 업무 효율성을 향상시키기 위해 기술적으로 개선하는 경우도 있습니다. 예를 들어, Avella Specialty Pharmacy는 미국 휴스턴에 본사를 둔 Advanced Pharma Inc. 14개 치료군에 걸쳐 다양한 제품을 공급하고 있는 FDA 등록 503B 아웃소싱 시설입니다.

목차

제1장 조제 약국 시장 개요

• 조사 범위
• 시장 추정 연수

제2장 주요 요약

• 시장 내역
• 경쟁 인사이트

제3장 조제 약국 주요 시장 동향

• 시장 성장 촉진요인
• 시장 성장 억제요인
• 시장 기회
• 향후 시장 동향

제4장 조제 약국 업계 조사

• PEST 분석
• Porter's Five Forces 분석
• 성장 전망 매핑
• 규제 체계 분석

제5장 조제 약국 시장 : COVID-19의 영향 분석

• 신종 코로나바이러스 감염증 이전의 영향 분석
• 신종 코로나바이러스 감염증 후의 영향 분석

제6장 조제 약국 시장 상황

• 조제 약국 시장 점유율 분석, 2022년
• 주요 제조업체별 내역 데이터
  • 기존 기업 분석
  • 신흥 기업 분석

제7장 조제 약국 시장 - 제품 유형별

• 개요
  • 제품 유형별 부문 점유율 분석
  • 경구제
    • 캡슐
    • 태블릿
    • 혼합
    • 롤리팝
    • 트로키
  • 국소제
    • 젤
    • 연고
    • 크림
    • 로션
  • 직장제
  • 비경구제
  • 비강제
  • 안과제
  • 세구제

제8장 조제 약국 시장 - 용도별

• 개요
  • 용도별 부문 점유율 분석
  • 소아
  • 성인
  • 고령자
  • 수의

제9장 조제 약국 시장 - 배합 유형별

• 개요
  • 부문 점유율 분석(배합 유형별)
  • 의약품 성분 변경(PIA)
  • 현재 이용할 수 없는 의약품 제조(CUPM)
  • 의약품 용량 변경(PDA)
  • 기타

제10장 조제 약국 시장 - 치료 분야별

• 개요
  • 치료 분야별 부문 점유율 분석
  • 통증 관리
  • 호르몬 대체요법(HRT)
  • 피부과
  • 특수 의약품

제11장 조제 약국 시장 - 지역별

• 서론
• 북미
  • 개요
  • 북미의 주요 제조업체
  • 미국
  • 캐나다
• 유럽
  • 개요
  • 유럽의 주요 제조업체
  • 독일
  • 이탈리아
  • 영국
  • 프랑스
  • 러시아
  • 네덜란드
  • 스웨덴
  • 폴란드
  • 기타
• 아시아태평양
  • 개요
  • 아시아태평양의 주요 제조업체
  • 인도
  • 중국
  • 일본
  • 한국
  • 호주
  • 태국
  • 인도네시아
  • 필리핀
  • 기타
• 라틴아메리카
  • 개요
  • 라틴아메리카의 주요 제조업체
  • 브라질
  • 멕시코
  • 아르헨티나
  • 콜롬비아
  • 기타
• 중동 및 아프리카
  • 개요
  • 중동 및 아프리카의 주요 제조업체
  • 사우디아라비아
  • 아랍에미리트
  • 이스라엘
  • 터키
  • 알제리
  • 이집트
  • 기타

제12장 주요 벤더 분석 - 조제 약국 업계

• 경쟁 대시보드
• 기업 개요
  • Avella Specialty Pharmacy
  • Central Admixture Pharmacy Services
  • Fagron
  • Fresenius Kabi AG
  • PharMEDium Services
  • Institutional Pharmacy Solutions
  • Cantrell Drug Company
  • Triangle Compounding Pharmacies
  • Lorraine's Pharmacy
  • Rx3 Compounding Pharmacy
  • B Braun Melsungen AG
  • Clinigen Group PLC
  • QuVa Pharma
  • ITC Compounding Pharmacy
  • Advanced Pharmacy.

제13장 애널리스트의 전방위 전망

ksm

영문 목차

영문목차

REPORT HIGHLIGHT

Compounding Pharmacies Market size was valued at USD 12,608.7 Million in 2022, expanding at a CAGR of 6.3% from 2023 to 2030.

Compounding pharmacies have a unique and crucial function in the pharmaceutical sector. By blending, modifying, or combining two or more substances to match a patient's unique needs, pharmacists create customized prescriptions for their patients. In order to create a compounded medicine, compounding pharmacies must use only pure, pharmaceutical-grade ingredients. These have to be manufactured in a setting that has an FDA registration. Compound and conventional medications are labeled differently in several cases. unlike labels for FDA-approved pharmaceuticals, compounded medicine labels don't adhere to a specific structure. The laws governing them differ as well.

Compounding Pharmacies Market - Market Dynamics:

• Increasing prevalence of chronic disease, increase in old age population, and improved life expectancy expected to propel market demand

• Long-term treatment is frequently necessary for chronic disorders. Compounding pharmacies can adapt pharmaceuticals to a patient's unique requirements, maximizing dosages and forms, or otherwise improving their effectiveness or tolerability for patients with particular demands. According to the National Health Council, generally incurable and ongoing, chronic diseases affect approximately 133 million Americans, representing more than 40% of the total population of this country. By 2020, that number is projected to grow to an estimated 157 million, with 81 million having multiple conditions. There is a greater need for specialist geriatric care as there are more senior people, both in terms of medical services and facilities designed for this age group. The emphasis on preventative medicine to ensure quality of life grows as life expectancy rises. This may strengthen the wellness, nutrition, and screening industries. Significant opportunity for development is offered by developing nations. The need for customized treatments could increase as awareness and income levels improve in these areas. However, the severe regulatory supervision that compounding pharmacies occasionally experience can be problematic. It hampers the market growth.

Compounding Pharmacies Market - Key Insights:

• As per the analysis shared by our research analyst, the global Compounding Pharmacies market is estimated to grow annually at a CAGR of around 6.3% over the forecast period (2023-2030)

• The Compounding Pharmacies industry is projected to grow at a significant rate due to the growing awareness of sustainable growth

• Based on Product type segmentation, Oral was predicted to show maximum market share in the year 2022

• Based on Therapeutic Area segmentation, Hormone Replacement Therapy (HRT) was the leading type in 2022

• Based on Application segmentation, Geriatric was the leading type in 2022

• On the basis of region, North America was the leading revenue generator in 2022

Compounding Pharmacies Market- Segmentation Analysis:

• The Global Compounding Pharmacies Market is segmented based on Product Type, Therapeutic Areas, Application, Compounding Type, and Region.

• The market is divided into seven categories based on product type: Oral, Topical, Rectal, Parenteral, Nasal, Ophthalmic, and Mouthwashes. The oral segment dominates the market. Due to its ease of administration, patient compliance, and diversity in formulation (such as tablets, capsules, liquids, and suspensions), the oral route remains one of the most popular drug delivery modalities.

• The market is divided into four categories based on Therapeutic Areas: Pain Management, Hormone Replacement Therapy (HRT), Dermatology, and Specialty Drugs. Hormone Replacement Therapy (HRT) segment dominates the market. Compounding pharmacies play an important part in the field of Hormone Replacement Therapy (HRT). HRT is the use of hormones to treat hormonal abnormalities in the body, which are frequently associated with menopause, andropause (sometimes known as "male menopause"), or certain endocrine illnesses.

• The market is divided into four categories based on Application: Pediatric, adult, Geriatric, and Veterinary. The Geriatric application dominates the market and is likely to maintain its dominance during the forecast period. Compounding pharmacies play an important part in the geriatric healthcare sector. Because of factors such as polypharmacy (taking numerous medications), age-related physiological changes, specific drug sensitivities, and drug administration problems, the aged population frequently has unique prescription needs.

Compounding Pharmacies Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the growth of the market, due to High regional awareness regarding compounding medications, and an increasing number of healthcare facilities. Over the years, the US and Canada have made considerable investments in healthcare infrastructure. This covers not only hospitals but also specialty clinics, nursing homes, and other care settings where compounded pharmaceuticals can be beneficial. The U.S. Health Care from a Global Perspective predicted that in 2021, the U.S. spent 17.8 percent of gross domestic product (GDP) on health care, nearly twice as much as the average OECD country. Europe is the second-largest market for Compounding Pharmacies, due to high awareness, regulatory clarity, economic strength, and technological innovation.

Compounding Pharmacies Market- Competitive Landscape:

As with many sectors, the competitive landscape of the compounding pharmacies industry is defined by the existence of many main players, regional players, and local, independent pharmacies. These organizations frequently compete on the basis of quality, service range, regulatory compliance, technical improvements, and geographic coverage. The market share will differ depending on the location and the precise niche within compounding that each company occupies. In terms of revenue, larger businesses with several locations may dominate, although local, independent pharmacies may hold major shares in local marketplaces.

Some pharmacies may use technology improvements to improve compounding precision, quality control, or operational efficiency. For Example, Avella Specialty Pharmacy has signed a definitive agreement to acquire Houston-based Advanced Pharma Inc., an FDA-registered 503B outsourcing facility providing compounded products across 14 therapeutic classes to hospitals, health systems, and ambulatory surgery centers nationwide.

Recent Developments:

On Oct. 11, 2018, Fresenius Kabi announced currently it has opened a new pharmaceutical compounding center in Mississauga, Ontario. The center features state-of-the-art manufacturing technology and processes designed to meet rigorous quality standards and increased capacity needs of customers. The facility produces compounded pharmaceuticals for Canadian hospitals.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMPOUNDING PHARMACIES MARKET KEY PLAYERS

• Avella Specialty Pharmacy
• Central Admixture Pharmacy Services
• Fagron
• Fresenius Kabi AG
• PharMEDium Services
• Institutional Pharmacy Solutions
• Cantrell Drug Company
• Triangle Compounding Pharmacies
• Lorraine's Pharmacy
• Rx3 Compounding Pharmacy
• B Braun Melsungen AG
• Clinigen Group PLC
• QuVa Pharma
• ITC Compounding Pharmacy
• Advanced Pharmacy

GLOBAL COMPOUNDING PHARMACIES MARKET, BY PRODUCT TYPE

• Oral
• Capsule
• Tablets
• Mixtures
• Lollipops
• Lozenges
• Topical
• Gels
• Ointments
• Cream
• Lotions
• Rectal
• Parenteral
• Nasal
• Ophthalmic
• Mouthwashes

GLOBAL COMPOUNDING PHARMACIES MARKET, BY THERAPEUTIC AREA

• Pain Management
• Hormone Replacement Therapy (HRT)
• Dermatology
• Specialty Drugs

GLOBAL COMPOUNDING PHARMACIES MARKET, BY APPLICATION

• Pediatric
• Adults
• Geriatric
• Veterinary

GLOBAL COMPOUNDING PHARMACIES MARKET, BY COMPOUNDING TYPE

• Pharmaceutical Ingredient Alteration (PIA)
• Pharmaceutical Dosage Alteration (PDA)
• Currently Unavailable Pharmaceutical Manufacturing (CUPM)
• Others

GLOBAL COMPOUNDING PHARMACIES MARKET, BY REGION

• North America
• The U.S.
• Canada

• Europe
• Germany
• France
• Italy
• Spain
• United Kingdom
• Russia
• Netherlands
• Sweden
• Poland
• Rest of Europe

• Asia Pacific
• India
• China
• South Korea
• Japan
• Australia
• Thailand
• Indonesia
• Philippines
• Rest of APAC

• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM

• The Middle East and Africa
• Saudi Arabia
• United Arab Emirates
• Israel
• Turkey
• Algeria
• Egypt
• Rest of MEA

Table of Contents

1. Compounding Pharmacies Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Compounding Pharmacies Market Snippet by Product Type
  • 2.1.2. Compounding Pharmacies Market Snippet by Application
  • 2.1.3. Compounding Pharmacies Market Snippet by Compounding Type
  • 2.1.4. Compounding Pharmacies Market Snippet by Therapeutic Areas
  • 2.1.5. Compounding Pharmacies Market Snippet by Country
  • 2.1.6. Compounding Pharmacies Market Snippet by Region
• 2.2. Competitive Insights

3. Compounding Pharmacies Key Market Trends

• 3.1. Compounding Pharmacies Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Compounding Pharmacies Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Compounding Pharmacies Market Opportunities
• 3.4. Compounding Pharmacies Market Future Trends

4. Compounding Pharmacies Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Compounding Pharmacies Market: COVID-19 Impact Analysis

• 5.1. Pre-COVID-19 Impact Analysis
• 5.2. Post-COVID-19 Impact Analysis
  • 5.2.1. Top Performing Segments
  • 5.2.2. Marginal Growth Segments
  • 5.2.3. Top Looser Segments
  • 5.2.4. Marginal Loss Segments

6. Compounding Pharmacies Market Landscape

• 6.1. Compounding Pharmacies Market Share Analysis, 2022
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Compounding Pharmacies Market - By Product Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product Type, 2022 & 2030 (%)
  • 7.1.2. Oral
    • 7.1.2.1. Capsule
    • 7.1.2.2. Tablets
    • 7.1.2.3. Mixtures
    • 7.1.2.4. Lollipops
    • 7.1.2.5. Lozenges
  • 7.1.3. Topical
    • 7.1.3.1. Gels
    • 7.1.3.2. Ointments
    • 7.1.3.3. Cream
    • 7.1.3.4. Lotions
  • 7.1.4. Rectal
  • 7.1.5. Parenteral
  • 7.1.6. Nasal
  • 7.1.7. Ophthalmic
  • 7.1.8. Mouthwashes

8. Compounding Pharmacies Market - By Application

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
  • 8.1.2. Pediatric
  • 8.1.3. Adults
  • 8.1.4. Geriatric
  • 8.1.5. Veterinary

9. Compounding Pharmacies Market - By Compounding Type

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Compounding Type, 2022 & 2030 (%)
  • 9.1.2. Pharmaceutical Ingredient Alteration (PIA)
  • 9.1.3. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
  • 9.1.4. Pharmaceutical Dosage Alteration (PDA)
  • 9.1.5. Others

10. Compounding Pharmacies Market - By Therapeutic Areas

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
  • 10.1.2. Pain Management
  • 10.1.3. Hormone Replacement Therapy (HRT)
  • 10.1.4. Dermatology
  • 10.1.5. Specialty Drugs

11. Compounding Pharmacies Market- By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. Compounding Pharmacies Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. Compounding Pharmacies Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.3.9. Italy
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.9.3. Italy Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.9.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.9.5. Italy Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.3.9.6. Italy Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.3.10. United Kingdom
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.10.3. United Kingdom Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.10.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.10.5. United Kingdom Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.3.10.6. United Kingdom Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.3.11. France
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.11.3. France Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.11.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.11.5. France Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.3.11.6. France Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.3.12. Russia
    • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.12.2. Russia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.12.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.12.4. Russia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.3.12.5. Russia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.3.13. Netherlands
    • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.13.2. Netherlands Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.13.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.13.4. Netherlands Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.3.13.5. Netherlands Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.14.2. Sweden Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.3.15. Poland
    • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.15.2. Poland Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.15.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.15.4. Poland Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.3.15.5. Poland Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.3.16. Rest of Europe
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.3.16.6. Rest of the Europe Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. Compounding Pharmacies Key Manufacturers in Asia Pacific
  • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.4.4. Asia Pacific Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 11.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.4.6. Asia Pacific Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
  • 11.4.7. Asia Pacific Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.4.8. India
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.8.3. India Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.8.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.8.5. India Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.4.8.6. India Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.4.9. China
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.9.3. China Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.9.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.9.5. China Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.4.9.6. China Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.4.13. Thailand
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.13.3. Thailand Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.13.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.13.5. Thailand Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.4.13.6. Thailand Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.4.14. Indonesia
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.14.3. Indonesia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.14.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.14.5. Indonesia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.4.14.6. Indonesia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.4.16. Rest of APAC
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.4.16.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.4.16.5. Rest of APAC Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.4.16.6. Rest of APAC Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
• 11.5. Latin America
  • 11.5.1. Overview
  • 11.5.2. Compounding Pharmacies Key Manufacturers in Latin America
  • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.5.4. Latin America Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 11.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.5.6. Latin America Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
  • 11.5.7. Latin America Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
• 11.6. Middle East and Africa
  • 11.6.1. Overview
  • 11.6.2. Compounding Pharmacies Key Manufacturers in Middle East and Africa
  • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
  • 11.6.4. Middle East and Africa Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
  • 11.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 11.6.6. Middle East and Africa Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
  • 11.6.7. Middle East and Africa Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)
  • 11.6.14. Rest of MEA
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
    • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2018 - 2030 (US$ Million)
    • 11.6.14.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 11.6.14.5. Rest of MEA Market Size and Forecast, By Compounding Type, 2018 - 2030 (US$ Million)
    • 11.6.14.6. Rest of MEA Market Size and Forecast, By Therapeutic Areas, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Compounding Pharmacies Industry

• 12.1. Competitive Dashboard
• 12.2. Company Profiles
  • 12.2.1. Avella Specialty Pharmacy
  • 12.2.2. Central Admixture Pharmacy Services
  • 12.2.3. Fagron
  • 12.2.4. Fresenius Kabi AG
  • 12.2.5. PharMEDium Services
  • 12.2.6. Institutional Pharmacy Solutions
  • 12.2.7. Cantrell Drug Company
  • 12.2.8. Triangle Compounding Pharmacies
  • 12.2.9. Lorraine's Pharmacy
  • 12.2.10. Rx3 Compounding Pharmacy
  • 12.2.11. B Braun Melsungen AG
  • 12.2.12. Clinigen Group PLC
  • 12.2.13. QuVa Pharma
  • 12.2.14. ITC Compounding Pharmacy
  • 12.2.15. Advanced Pharmacy.

13. 360 Degree Analyst View

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us

관련자료